Category: HCC In Focus
The Evolving Role of Combination Systemic Therapies in Hepatocellular Carcinoma
H&O What are the treatment goals in hepatocellular carcinoma? RK In hepatocellular carcinoma (HCC), the treatment goals depend on the stage of the cancer. For early-stage […]
Exploring the Potential Chemoprophylactic Role of Carvedilol for Hepatocellular Carcinoma
H&O What are the notable risk factors for hepatocellular carcinoma? RS The main risk factor for hepatocellular carcinoma (HCC) is liver cirrhosis. A damaged liver with […]
How to Choose Second-Line Treatment for Hepatocellular Carcinoma
H&O What are the current options for first-line medical treatment of hepatocellular carcinoma? CF Recently, there has been a significant progression in the options that are […]
Liver Transplant and Hepatocellular Carcinoma
Clinical Advances in Hematology & Oncology December 2016, Volume 14, Issue 12 Robert Wong, MD, MS Assistant Clinical Professor of Medicine Director of Research and Education […]
The Role of Liver Biopsy in Hepatocellular Carcinoma
Clinical Advances in Hematology & Oncology October 2016, Volume 14, Issue 10 Richard S. Finn, MD Associate Professor of Medicine Department of Medicine Division of Hematology/Oncology […]
Sorafenib in Combination With Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
Clinical Advances in Hematology & Oncology Volume 14, Issue 8, August 2016 Jean-Francois H. Geschwind, MD Chairman, Department of Radiology and Biomedical Imaging Professor of Radiology […]
Surveillance for Hepatocellular Carcinoma
Clinical Advances in Hematology & Oncology Volume 14, Issue 6, June 2016 Catherine Frenette, MD Medical Director of Liver Transplantation Scripps Center for Organ Transplantation La […]
Biomarkers for Hepatocellular Carcinoma
Clinical Advances in Hematology & Oncology April 2016, Volume 14, Issue 4 Lewis R. Roberts, MB ChB, PhD Professor of Medicine Department of Gastroenterology and Hepatology […]
The Relationship Between Hepatocellular Carcinoma and Hepatitis B and C Virus
Clinical Advances in Hematology & Oncology February 2016, Volume 14, Issue 2 Anita Kohli, MD, MS Infectious Disease Physician/Scientist Chair of Research, Department of Medicine Director […]
The Use of Genetic Alterations in the Development of Liver Cancer Drugs
Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Ghassan K. Abou-Alfa, MD Associate Professor Gastrointestinal Oncology Service Memorial Sloan Kettering Cancer Center […]
Locoregional Therapy for Patients With Hepatocellular Carcinoma
Jean-Francois H. Geschwind, MD Professor of Radiology and Oncology Chairman, Department of Diagnostic Radiology Yale School of Medicine New Haven, Connecticut H&O What are the most […]
Treatment of Intermediate-Stage Hepatocellular Carcinoma
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Richard S. Finn, MD Associate Professor of Medicine Department of Medicine, Division of […]
Imaging Techniques for Hepatocellular Carcinoma
Volume 13, Issue 6 June 2015 Claude Sirlin, MD Professor of Radiology University of California, San Diego San Diego, California H&O Is there a standardized protocol […]